Clopidogrel adherence

Ann Pharmacother. 2009 Feb43(2):259-67. doi: 10.1345aph.1L286. Epub 2009 Feb 3. Barriers to clopidogrel adherence following placement of drug-eluting We did not simultaneously assess non-adherence to clopidogrel, as no distinguishing platelet function tests are currently able to discriminate non- responders

Results 1 - 10 436 Barriers to Clopidogrel Adherence Followingof Drug-Eluting Stents Maria Jos Pallares80 adherence to clopidogrel. Patients were

7 Jul 2011 Predictors of low clopidogrel adherence following percutaneous coronary intervention. Muntner P, Mann DM, Woodward M, Choi JW, Stoler RC Inappropriate clopidogrel adherence explains stent related adverse outcomes. Leonardo Tamariz, MD, MPH. University of Miami. Antiplatelet use post-stent 20 Jul 2011 Patients39 record of adherence to daily medications before undergoing percutaneous coronary intervention (PCI) is a reliable guide to how well

Barriers to clopidogrel adherence following placement of drug

23 Jul 2009 The purpose of this study is to test the impact of a multidisciplinary approach to improve the adhesion and persistence to Clopidogrel therapy 11 Mar 2013 Non-adherence with clopidogrel after coronary stenting may be associated with an adverse outcome. We analysed province-wide data to

Background: Clopidogrel non-adherence is a strong predictor of stent thrombosis , myocardial infarction, and death after drug-eluting stent (DES) placement 18 Jan 2011 Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous